Annasaheb Kolpe

Dr
Annasaheb
Kolpe

Associate Director and Head-R&D
Hester Biosciences
Biography
Virologist, vaccinologist, and a research veterinarian with extensive experience in viral vaccines, antivirals, monoclonal antibody, and animal models development.
Research interests
Virology; Vaccinology; Biologics; Immunology; Infectious Diseases; Biosafety (level 2, 3, 4); Antiviral Drug Development; Bioassay Development; Animal Models; One Health, Human and Veterinary Medicine
Projects you're working on

Sheep pox vaccine development, Canine distemper vaccine development, Classical swine fever vaccine development, Poultry vaccine development, Animal health, Animal health product development, Brucella vaccine development, ILT, Avian influenza, ND, IBD, Coryza

 

Discipline
Bacteriology Bio-manufacturing Bioinformatics Cellular biology Challenge model development Challenge study design Clinical trials – efficacy Clinical trials – safety Commercialisation Deployment Economics Epidemiology Ethics Formulation technology Immunology – B-cells Immunology – T-cells Immunology – innate Molecular biology Parasitology Pharmacovigilance Protein biology QC test development Quality assurance Registration Regulation Safety evaluation Social sciences Statistics Structural biology Systems biology Virology
Host species
Buffalo Camels Cats Cattle Dogs Fish Horses Pigs Poultry Small ruminants Wildlife Zoonoses
Pathogen
Bacteria Bacteria›Aeromonas Bacteria›Brucella Bacteria›Chlamydophila Bacteria›Clostridia Bacteria›Corynebacterium Bacteria›E. coli Bacteria›Erysipelas Bacteria›Leptospira Bacteria›M. hyo Bacteria›Mycobacteria bovis Bacteria›Salmonella Bacteria›Yersinia Parasites Parasites›Babesia Parasites›Cestodes Parasites›Eimeria Parasites›Nematodes Parasites›Neospora Parasites›Taenia solium Parasites›Theileria annulata Parasites›Theileria parva Parasites›Ticks Parasites›Trypanosoma Viruses Viruses›Adenovirus Viruses›African horse sickness virus Viruses›African swine fever virus Viruses›Arboviruses Viruses›Arteriviruses Viruses›Avian papillomavirus Viruses›Avian polyomavirus Viruses›Bluetongue virus Viruses›Bovine ephemeral fever virus Viruses›Bovine viral diarrhoea Viruses›Calicivirus Viruses›Capripoxvirus Viruses›Chicken anaemia virus Viruses›Classical swine fever virus Viruses›Coronavirus Viruses›Crimean-Congo haemorrhagic fever virus Viruses›Cytomegalovirus Viruses›Ebolaviruses/filoviruses Viruses›Feline leukaemia virus Viruses›Foot-and-mouth disease virus Viruses›Herpesvirus Viruses›Infectious bursal disease virus Viruses›Infectious pancreatic necrosis virus Viruses›Infectious salmon anaemia virus Viruses›Influenza virus Viruses›Mareks disease virus Viruses›Nairoviruses Viruses›Newcastle disease virus Viruses›Nipah virus Viruses›Parainfluenza virus Viruses›Paramyxoviruses Viruses›Parvovirus Viruses›Peste des petits ruminants virus Viruses›Piscine novirhabdovirus Viruses›Porcine circovirus Viruses›Porcine reproductive and respiratory syndrome virus Viruses›Poxviruses Viruses›Rabies virus Viruses›Respiratory syncytial virus Viruses›Retroviruses Viruses›Rift Valley fever virus Viruses›Rotavirus
Stage of vaccine development
Adjuvants Antigen discovery and immunogen design Clinical trials Commercialisation Correlates of protection – immunomonitoring Deployment Field trials Marketing Pre-clinical trials Vaccine delivery